Publication:
Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis.

cris.virtual.author-orcid0000-0001-6818-0931
cris.virtual.author-orcid0000-0001-7637-0559
cris.virtual.author-orcid0000-0001-8331-5902
cris.virtualsource.author-orcidfd03e4f7-84bb-44d4-86cb-f8e880212e49
cris.virtualsource.author-orcid561427a0-4730-4414-986f-892ab0fc62b0
cris.virtualsource.author-orcid25ae41a1-0047-43ca-b38c-06dd14696e1b
cris.virtualsource.author-orcid4b0f2ded-f422-434d-8fe7-be7a982e259c
cris.virtualsource.author-orcidbf17726e-550a-4bad-9c1a-89b206d37c65
cris.virtualsource.author-orcid1b63c9a4-1fc4-4557-beaa-ed188fdb7d15
cris.virtualsource.author-orcid324fe5e8-9de1-4ae3-b4c9-47c8ccc99795
datacite.rightsopen.access
dc.contributor.authorWróbel, Tomasz M
dc.contributor.authorSharma, Katyayani
dc.contributor.authorMannella, Iole
dc.contributor.authorOliaro-Bosso, Simonetta
dc.contributor.authorNieckarz, Patrycja
dc.contributor.authordu Toit, Therina
dc.contributor.authorVögel, Clarissa
dc.contributor.authorRojas Velazquez, Maria Natalia
dc.contributor.authorYakubu, Jibira
dc.contributor.authorMatveeva, Anna
dc.contributor.authorTherkelsen, Søren
dc.contributor.authorJørgensen, Flemming Steen
dc.contributor.authorPandey, Amit Vikram
dc.contributor.authorPippione, Agnese C
dc.contributor.authorLolli, Marco L
dc.contributor.authorBoschi, Donatella
dc.contributor.authorBjörkling, Fredrik
dc.date.accessioned2024-10-25T18:13:26Z
dc.date.available2024-10-25T18:13:26Z
dc.date.issued2023-09-05
dc.description.abstractThis study reports on the synthesis and evaluation of novel compounds replacing the nitrogen-containing heterocyclic ring on the chemical backbone structure of cytochrome P450 17α-hydroxylase/12,20-lyase (CYP17A1) inhibitors with a phenyl bearing a sulfur-based substituent. Initial screening revealed compounds with marked inhibition of CYP17A1 activity. The selectivity of compounds was thereafter determined against cytochrome P450 21-hydroxylase, cytochrome P450 3A4, and cytochrome P450 oxidoreductase. Additionally, the compounds showed weak inhibitory activity against aldo-keto reductase 1C3 (AKR1C3). The compounds' impact on steroid hormone levels was also assessed, with some notable modulatory effects observed. This work paves the way for developing more potent dual inhibitors specifically targeting CYP17A1 and AKR1C3.
dc.description.numberOfPages18
dc.description.sponsorshipUniversitätsklinik für Kinderheilkunde
dc.description.sponsorshipDepartment for BioMedical Research (DBMR)
dc.identifier.doi10.48350/186777
dc.identifier.pmid37759751
dc.identifier.publisherDOI10.3390/biom13091349
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/170335
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofBiomolecules
dc.relation.issn2218-273X
dc.relation.organizationDCD5A442BADAE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BB17E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BD18E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C248E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C266E17DE0405C82790C4DE2
dc.relation.schoolDCD5A442C27BE17DE0405C82790C4DE2
dc.subjectAKR1C3 CYP17A1 enzyme inhibition prostate cancer
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleExploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.issue9
oaire.citation.volume13
oairecerif.author.affiliationUniversitätsklinik für Kinderheilkunde
oairecerif.author.affiliationDepartment for BioMedical Research (DBMR)
oairecerif.author.affiliationDepartment for BioMedical Research (DBMR)
oairecerif.author.affiliationUniversitätsklinik für Kinderheilkunde
oairecerif.author.affiliationDepartment for BioMedical Research (DBMR)
oairecerif.author.affiliationUniversitätsklinik für Kinderheilkunde
oairecerif.author.affiliationUniversitätsklinik für Kinderheilkunde
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Endokrinologie / Diabetologie / Metabolik (Pädiatrie)
oairecerif.author.affiliation2Universitätsklinik für Nephrologie und Hypertonie
oairecerif.author.affiliation2Universitätsklinik für Kinderheilkunde - Endokrinologie / Metabolismus
oairecerif.author.affiliation2Department for BioMedical Research (DBMR)
oairecerif.author.affiliation3Department for BioMedical Research, Forschungsgruppe Endokrinologie / Diabetologie / Metabolik (Pädiatrie)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2023-10-02 08:24:48
unibe.description.ispublishedpub
unibe.eprints.legacyId186777
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
biomolecules-13-01349.pdf
Size:
3.77 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections